{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:52:19Z","timestamp":1781711539405,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"General Organization For Teaching Hospitals and Institutes"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetic nephropathy (DN), indicated by persistent urinary albumin excretion or albuminuria, is the major cause of end stage renal disease worldwide. Currently albuminuria is considered the best predictor of subsequent development of DN in type 2 diabetic patients, but it is often induced by arterial hypertension or heart failure in older patients as well. Therefore, additional biomarkers are needed to identify diabetic patients at a high risk of developing DN. The aim of the study was to investigate the expression profiles of some serum proteome biomarkers and to demonstrate their association with early renal alterations among type 2 diabetic patients. This study included 300 type 2 diabetic patients with- (200, UACR\u2009&gt;\u200930\u00a0mg\/gm) and without- (100, UACR\u2009&lt;\u200930\u00a0mg\/gm) persistent albuminuria in addition to 100 healthy control subjects. Serum expression patterns of KNG-1, HSPG, Robo4 and other biochemical parameters were evaluated in all participants. We also assessed the combined influence of hypertension and albuminuria on these markers, to explore their potential as non-invasive indicators of early renal risk in T2DM. Results suggest that elevated serum KNG-1, HSPG and Robo4 levels in type 2 diabetic patients might reflect a DN progressive pathology due to various mechanisms. The interaction between hypertension and albuminuria significantly alters biomarker levels in a synergistic manner, emphasizing the need for comprehensive management of both conditions in clinical practice. Additionally, findings highlight that serum proteome signature of these biomarkers provide an incremental predictive value when integrated with conventional clinical parameters, as evidenced by the marked improvement in multivariable regression model performance and discriminative accuracy analyses.<\/jats:p>","DOI":"10.1038\/s41598-026-57087-z","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:24:11Z","timestamp":1781702651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KNG-1, HSPG and Robo4 reflect hypertension-driven subclinical renal alterations and provide incremental diagnostic value in type 2 diabetic nephropathy"],"prefix":"10.1038","volume":"16","author":[{"given":"Heba Ibrahim","family":"Hamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5279-2167","authenticated-orcid":false,"given":"Ashraf Ismail","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-1342","authenticated-orcid":false,"given":"Heba Ramadan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5737-1166","authenticated-orcid":false,"given":"Ahmed M. A.","family":"Akabawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"57087_CR1","doi-asserted-by":"crossref","unstructured":"Azagew, A. W., Beko, Z. W. & Mekonnen, C. K. Determinants of diabetic nephropathy among diabetic patients in Ethiopia: Systematic review and meta-analysis. PloS one 19, (2), e0297082. (2024).","DOI":"10.1371\/journal.pone.0297082"},{"issue":"6","key":"57087_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/0971-4065.176144","volume":"26","author":"RK Marikanty","year":"2016","unstructured":"Marikanty, R. K. et al. Identification of urinary proteins potentially associated with diabetic kidney disease. Indian J. Nephrol. 26 (6), 434\u2013445 (2016).","journal-title":"Indian J. Nephrol."},{"key":"57087_CR3","doi-asserted-by":"publisher","first-page":"816400","DOI":"10.3389\/fendo.2022.816400","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang, J. & Liu, Z. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy. Front. Endocrinol. 13, 816400 (2022).","journal-title":"Front. Endocrinol."},{"key":"57087_CR4","doi-asserted-by":"publisher","first-page":"1356131","DOI":"10.3389\/fendo.2024.1356131","volume":"15","author":"X Cao","year":"2024","unstructured":"Cao, X. et al. Diagnostic value of retinol-binding protein 4 in diabetic nephropathy: a systematic review and meta-analysis. Front. Endocrinol. 15, 1356131 (2024).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"57087_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13046-018-0833-0","volume":"37","author":"J Xu","year":"2018","unstructured":"Xu, J. et al. Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells. J. Exp. Clin. Cancer Res. 37 (1), 180 (2018).","journal-title":"J. experimental Clin. cancer research: CR"},{"key":"57087_CR6","doi-asserted-by":"crossref","unstructured":"Ponczek, M. B. High Molecular Weight Kininogen: A Review of the Structural Literature. Inter. J. Molecular Sci. 22, (24). (2021).","DOI":"10.3390\/ijms222413370"},{"key":"57087_CR7","doi-asserted-by":"crossref","unstructured":"Dhounchak, S. et al. Heparan sulfate proteoglycans in beta cells provide a critical link between endoplasmic reticulum stress, oxidative stress and type 2 diabetes. PloS one 16, (6), e0252607. (2021).","DOI":"10.1371\/journal.pone.0252607"},{"issue":"1","key":"57087_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12020-019-01921-0","volume":"65","author":"Q Gong","year":"2019","unstructured":"Gong, Q., Li, F., Xie, J., Su, G. & Upregulated, V. E. G. F. Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy. Endocrine 65 (1), 35\u201345 (2019).","journal-title":"Endocrine"},{"issue":"Suppl 1","key":"57087_CR9","first-page":"S42","volume":"30","author":"Diagnosis and classification of diabetes mellitus","year":"2007","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care 30 Suppl 1, S42\u2013S47. (2007).","journal-title":"Diabetes Care"},{"issue":"9414","key":"57087_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0140-6736(04)15856-X","volume":"363","author":"K Shiwaku","year":"2004","unstructured":"Shiwaku, K., Anuurad, E., Enkhmaa, B., Kitajima, K. & Yamane, Y. Appropriate BMI for Asian populations. Lancet (London England). 363 (9414), 1077 (2004).","journal-title":"Lancet (London England)"},{"issue":"3","key":"57087_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz, G. J. et al. New equations to estimate GFR in children with CKD. J. Am. Soc. Nephrol. JASN. 20 (3), 629\u2013637 (2009).","journal-title":"J. Am. Soc. Nephrology: JASN"},{"issue":"4","key":"57087_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.2337\/diacare.29.04.06.dc06-1555","volume":"29","author":"TI Justesen","year":"2006","unstructured":"Justesen, T. I., Petersen, J. L., Ekbom, P., Damm, P. & Mathiesen, E. R. Albumin-to-creatinine ratio in random urine samples might replace 24-h urine collections in screening for micro- and macroalbuminuria in pregnant woman with type 1 diabetes. Diabetes Care. 29 (4), 924\u2013925 (2006).","journal-title":"Diabetes Care"},{"issue":"151","key":"57087_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1039\/an9729700142","volume":"97","author":"D Barham","year":"1972","unstructured":"Barham, D. & Trinder, P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 97 (151), 142\u2013145 (1972).","journal-title":"Analyst"},{"issue":"4","key":"57087_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","volume":"20","author":"CC Allain","year":"1974","unstructured":"Allain, C. C., Poon, L. S., Chan, C. S., Richmond, W. & Fu, P. C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20 (4), 470\u2013475 (1974).","journal-title":"Clin. Chem."},{"issue":"3","key":"57087_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/clinchem\/29.3.538","volume":"29","author":"MW McGowan","year":"1983","unstructured":"McGowan, M. W., Artiss, J. D., Strandbergh, D. R. & Zak, B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 29 (3), 538\u2013542 (1983).","journal-title":"Clin. Chem."},{"issue":"6","key":"57087_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/clinchem\/24.6.931","volume":"24","author":"PR Finley","year":"1978","unstructured":"Finley, P. R., Schifman, R. B., Williams, R. J. & Lichti, D. A. Cholesterol in high-density lipoprotein: use of Mg2+\/dextran sulfate in its enzymic measurement. Clin. Chem. 24 (6), 931\u2013933 (1978).","journal-title":"Clin. Chem."},{"issue":"6","key":"57087_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (6), 499\u2013502 (1972).","journal-title":"Clin. Chem."},{"issue":"8","key":"57087_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/clinchem\/18.8.829","volume":"18","author":"TO Tiffany","year":"1972","unstructured":"Tiffany, T. O., Jansen, J. M., Burtis, C. A., Overton, J. B. & Scott, C. D. Enzymatic kinetic rate and end-point analyses of substrate, by use of a GeMSAEC fast analyzer. Clin. Chem. 18 (8), 829\u2013840 (1972).","journal-title":"Clin. Chem."},{"issue":"10","key":"57087_CR19","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/clinchem\/22.10.1664","volume":"22","author":"J Vasiliades","year":"1976","unstructured":"Vasiliades, J. Reaction of alkaline sodium picrate with creatinine: I. Kinetics and mechanism of formation of the mono-creatinine picric acid complex. Clin. Chem. 22 (10), 1664\u20131671 (1976).","journal-title":"Clin. Chem."},{"issue":"2","key":"57087_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/104063870501700214","volume":"17","author":"F Gentilini","year":"2005","unstructured":"Gentilini, F. et al. Validation of a human immunoturbidimetric assay to measure canine albumin in urine and cerebrospinal fluid. J. Veterinary Diagn. Investig. 17 (2), 179\u2013183 (2005).","journal-title":"J. veterinary Diagn. investigation: official publication Am. Association Veterinary Lab. Diagnosticians Inc"},{"issue":"1","key":"57087_CR21","first-page":"57","volume":"61","author":"N Vinter-Repalust","year":"2007","unstructured":"Vinter-Repalust, N., Jurkovi\u0107, L., Kati\u0107, M., Simunovi\u0107, R. & Petric, D. [Disease duration, patient compliance and presence of complications in diabetic patients]. Acta Med. Croatica: casopis Hravatske akademije medicinskih znanosti. 61 (1), 57\u201362 (2007).","journal-title":"Acta Med. Croatica: casopis Hravatske akademije medicinskih znanosti"},{"issue":"12","key":"57087_CR22","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","volume":"57","author":"S Zoungas","year":"2014","unstructured":"Zoungas, S. et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia 57 (12), 2465\u20132474 (2014).","journal-title":"Diabetologia"},{"issue":"02","key":"57087_CR23","first-page":"93","volume":"124","author":"RC Stanton","year":"2016","unstructured":"Stanton, R. C. Diabetic Kidney Disease and Hypertension. Exp. Clin. Endocrinol. Diabetes. 124 (02), 93\u201398 (2016).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"57087_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.ackd.2010.10.003","volume":"18","author":"PN Van Buren","year":"2011","unstructured":"Van Buren, P. N. & Toto, R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv. Chronic Kidney Dis. 18 (1), 28\u201341 (2011).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"57087_CR25","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska, E. et al. Novel Insights into Diabetic Kidney Disease. Inter. J. Molecular Sci. 25, (18). (2024).","DOI":"10.3390\/ijms251810222"},{"key":"57087_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000324934","volume":"170","author":"AT Reutens","year":"2011","unstructured":"Reutens, A. T. & Atkins, R. C. Epidemiology of diabetic nephropathy. Contrib. Nephrol. 170, 1\u20137 (2011).","journal-title":"Contrib. Nephrol."},{"key":"57087_CR27","doi-asserted-by":"publisher","first-page":"19667","DOI":"10.1038\/srep19667","volume":"6","author":"L Gonzalez-Calero","year":"2016","unstructured":"Gonzalez-Calero, L. et al. Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis? Sci. Rep. 6, 19667 (2016).","journal-title":"Sci. Rep."},{"issue":"6","key":"57087_CR28","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/ki.2013.8","volume":"83","author":"ML Merchant","year":"2013","unstructured":"Merchant, M. L. et al. Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. Kidney Int. 83 (6), 1177\u20131184 (2013).","journal-title":"Kidney Int."},{"issue":"5","key":"57087_CR29","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2337\/diabetes.52.5.1215","volume":"52","author":"AA Jaffa","year":"2003","unstructured":"Jaffa, A. A. et al. Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. Diabetes 52 (5), 1215\u20131221 (2003).","journal-title":"Diabetes"},{"key":"57087_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","volume":"42","author":"RV Iozzo","year":"2015","unstructured":"Iozzo, R. V. & Schaefer, L. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol. J. Int. Soc. Matrix Biol. 42, 11\u201355 (2015).","journal-title":"Matrix biology: J. Int. Soc. Matrix Biology"},{"issue":"2","key":"57087_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI200113530","volume":"108","author":"JD Esko","year":"2001","unstructured":"Esko, J. D. & Lindahl, U. Molecular diversity of heparan sulfate. J. Clin. Investig. 108 (2), 169\u2013173 (2001).","journal-title":"J. Clin. Investig."},{"issue":"3","key":"57087_CR32","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1523-1755.2004.00451.x","volume":"65","author":"AL Rops","year":"2004","unstructured":"Rops, A. L. et al. Heparan sulfate proteoglycans in glomerular inflammation. Kidney Int. 65 (3), 768\u2013785 (2004).","journal-title":"Kidney Int."},{"issue":"1","key":"57087_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/S1431927611012682","volume":"18","author":"KJ McCarthy","year":"2012","unstructured":"McCarthy, K. J. & Wassenhove-McCarthy, D. J. The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans. Microscopy Microanal. 18 (1), 3\u201321 (2012).","journal-title":"Microscopy microanalysis: official J. Microscopy Soc. Am. Microbeam Anal. Soc. Microscopical Soc. Can."},{"issue":"12","key":"57087_CR34","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1369\/0022155412465073","volume":"60","author":"SO Kolset","year":"2012","unstructured":"Kolset, S. O., Reinholt, F. P. & Jenssen, T. Diabetic nephropathy and extracellular matrix. J. Histochem. cytochem. 60 (12), 976\u2013986 (2012).","journal-title":"J. Histochem. cytochemistry: official J. Histochem. Soc."},{"issue":"2","key":"57087_CR35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00125-007-0879-6","volume":"51","author":"TJ Wijnhoven","year":"2008","unstructured":"Wijnhoven, T. J. et al. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy. Diabetologia 51 (2), 372\u2013382 (2008).","journal-title":"Diabetologia"},{"key":"57087_CR36","doi-asserted-by":"crossref","unstructured":"Dai, C., Gong, Q., Cheng, Y. & Su, G. Regulatory mechanisms of Robo4 and their effects on angiogenesis. Biosci. Rep. 39, (7). (2019).","DOI":"10.1042\/BSR20190513"},{"key":"57087_CR37","first-page":"872","volume":"19","author":"P Na Nakorn","year":"2020","unstructured":"Na Nakorn, P. et al. Roles of kininogen-1, basement membrane specific heparan sulfate proteoglycan core protein, and roundabout homolog 4 as potential urinary protein biomarkers in diabetic nephropathy. Excli J. 19, 872\u2013891 (2020).","journal-title":"Excli j."},{"issue":"10","key":"57087_CR38","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1182\/blood.V90.10.3819","volume":"90","author":"RW Colman","year":"1997","unstructured":"Colman, R. W. & Schmaier, A. H. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90 (10), 3819\u20133843 (1997).","journal-title":"Blood"},{"issue":"8","key":"57087_CR39","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ki.2011.499","volume":"81","author":"H Tomita","year":"2012","unstructured":"Tomita, H., Sanford, R. B., Smithies, O. & Kakoki, M. The kallikrein-kinin system in diabetic nephropathy. Kidney Int. 81 (8), 733\u2013744 (2012).","journal-title":"Kidney Int."},{"key":"57087_CR40","doi-asserted-by":"crossref","unstructured":"Campbell, D. J., Kladis, A. & Duncan, A. M. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension (Dallas, Tex. (4), 439\u2009\u2013\u200949. (1979).","DOI":"10.1161\/01.HYP.23.4.439"},{"issue":"2","key":"57087_CR41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/j.2040-4603.2011.tb00347.x","volume":"1","author":"NE Rhaleb","year":"2011","unstructured":"Rhaleb, N. E., Yang, X. P. & Carretero, O. A. The kallikrein-kinin system as a regulator of cardiovascular and renal function. Compr. Physiol. 1 (2), 971\u2013993 (2011).","journal-title":"Compr. Physiol."},{"issue":"4","key":"57087_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","volume":"16","author":"SCW Tang","year":"2020","unstructured":"Tang, S. C. W. & Yiu, W. H. Innate immunity in diabetic kidney disease. Nat. Rev. Nephrol. 16 (4), 206\u2013222 (2020).","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"57087_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/157016112798829823","volume":"10","author":"L Ghiadoni","year":"2012","unstructured":"Ghiadoni, L., Taddei, S. & Virdis, A. Hypertension and endothelial dysfunction: therapeutic approach. Curr. Vasc. Pharmacol. 10 (1), 42\u201360 (2012).","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"1","key":"57087_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11906-006-0045-4","volume":"8","author":"S Taddei","year":"2006","unstructured":"Taddei, S., Virdis, A., Ghiadoni, L., Versari, D. & Salvetti, A. Endothelium, aging, and hypertension. Curr. Hypertens. Rep. 8 (1), 84\u201389 (2006).","journal-title":"Curr. Hypertens. Rep."},{"issue":"3","key":"57087_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1039\/C3IB40199E","volume":"6","author":"EE Ebong","year":"2014","unstructured":"Ebong, E. E., Lopez-Quintero, S. V., Rizzo, V., Spray, D. C. & Tarbell, J. M. Shear-induced endothelial NOS activation and remodeling via heparan sulfate, glypican-1, and syndecan-1. Integr. Biol. Quant. Biosci. nano macro. 6 (3), 338\u2013347 (2014).","journal-title":"Integr. biology: Quant. Biosci. nano macro"},{"issue":"6","key":"57087_CR46","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/cvr\/cvaa201","volume":"117","author":"M Mahmoud","year":"2021","unstructured":"Mahmoud, M. et al. The glycocalyx core protein Glypican 1 protects vessel wall endothelial cells from stiffness-mediated dysfunction and disease. Cardiovasc. Res. 117 (6), 1592\u20131605 (2021).","journal-title":"Cardiovasc. Res."},{"key":"57087_CR47","doi-asserted-by":"crossref","unstructured":"Kowalewska, P. M., Patrick, A. L. & Fox-Robichaud, A. E. Syndecan-1 in the mouse parietal peritoneum microcirculation in inflammation. PloS one 9, (9), e104537. (2014).","DOI":"10.1371\/journal.pone.0104537"},{"issue":"1","key":"57087_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bpj.2017.05.033","volume":"113","author":"AMW Bartosch","year":"2017","unstructured":"Bartosch, A. M. W., Mathews, R. & Tarbell, J. M. Endothelial Glycocalyx-Mediated Nitric Oxide Production in Response to Selective AFM Pulling. Biophys. J. 113 (1), 101\u2013108 (2017).","journal-title":"Biophys. J."},{"issue":"4","key":"57087_CR49","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.bbrc.2015.10.029","volume":"467","author":"Y Okada","year":"2015","unstructured":"Okada, Y. et al. Expression of the Robo4 receptor in endothelial cells is regulated by two AP-1 protein complexes. Biochem. Biophys. Res. Commun. 467 (4), 987\u2013991 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"57087_CR50","doi-asserted-by":"publisher","first-page":"F125","DOI":"10.1152\/ajprenal.00248.2009","volume":"298","author":"EA Jaimes","year":"2010","unstructured":"Jaimes, E. A., Hua, P., Tian, R. X. & Raij, L. Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am. J. Physiol. Renal. Physiol. 298 (1), F125\u2013F132 (2010).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"2","key":"57087_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1152\/physrev.00055.2006","volume":"88","author":"B Haraldsson","year":"2008","unstructured":"Haraldsson, B., Nystr\u00f6m, J. & Deen, W. M. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 88 (2), 451\u2013487 (2008).","journal-title":"Physiol. Rev."},{"issue":"8","key":"57087_CR52","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/hr.2013.22","volume":"36","author":"M Nishimura","year":"2013","unstructured":"Nishimura, M. et al. Significance of estimating the glomerular filtration rate for the management of hypertension in type 2 diabetes with microalbuminuria. Hypertens. Res. 36 (8), 705\u2013710 (2013).","journal-title":"Hypertens. research: official J. Japanese Soc. Hypertens."},{"issue":"10","key":"57087_CR53","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/hr.2012.112","volume":"35","author":"T Nagasawa","year":"2012","unstructured":"Nagasawa, T. et al. Albuminuria indicates the pressure-associated injury of juxtamedullary nephrons and cerebral strain vessels in spontaneously hypertensive stroke-prone rats. Hypertens. Res. 35 (10), 1024\u20131031 (2012).","journal-title":"Hypertens. research: official J. Japanese Soc. Hypertens."},{"issue":"3","key":"57087_CR54","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/MNH.0b013e3283522e7a","volume":"21","author":"B Haraldsson","year":"2012","unstructured":"Haraldsson, B. & Nystr\u00f6m, J. The glomerular endothelium: new insights on function and structure. Curr. Opin. Nephrol. Hypertens. 21 (3), 258\u2013263 (2012).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"9","key":"57087_CR55","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/hr.2013.44","volume":"36","author":"YS Kim","year":"2013","unstructured":"Kim, Y. S. et al. Prevalence of microalbuminuria and associated risk factors among adult Korean hypertensive patients in a primary care setting. Hypertens. Res. 36 (9), 807\u2013823 (2013).","journal-title":"Hypertens. research: official J. Japanese Soc. Hypertens."},{"issue":"9","key":"57087_CR56","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1007\/s00125-010-1810-0","volume":"53","author":"A Kuwabara","year":"2010","unstructured":"Kuwabara, A., Satoh, M., Tomita, N., Sasaki, T. & Kashihara, N. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 53 (9), 2056\u20132065 (2010).","journal-title":"Diabetologia"},{"issue":"3","key":"57087_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1055\/s-0041-1724118","volume":"47","author":"LM Hiebert","year":"2021","unstructured":"Hiebert, L. M. Heparan Sulfate Proteoglycans in Diabetes. Semin. Thromb. Hemost. 47 (3), 261\u2013273 (2021).","journal-title":"Semin. Thromb. Hemost."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57087-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:02:45Z","timestamp":1781708565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57087-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57087"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57087-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patient approved publishing all data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"18866"}}